The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks long-term capital appreciation.
The fund normally invests at least 65% of its total assets in equity securities of foreign issuers located in at least three countries outside the United States that the fund's investment adviser believes are likely to have rapid growth in revenues and earnings and potential for above-average capital appreciation. The advisor intends to invest in the securities of companies located in developed countries and, to a lesser extent, those located in emerging markets.
The average market capitalization across the Gabelli International Growth AAA MF is 42.5B. The market cap for tickers in the group ranges from 3.51M to 194.8B. AZN holds the highest valuation in this group at 194.8B. The lowest valued company is NOVN at 3.51M.
The average weekly volume growth across all stocks in the Gabelli International Growth AAA MF was -48%. For the same stocks of the MF, the average monthly volume growth was -52% and the average quarterly volume growth was -65%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 69
P/E Growth Rating: 66
Price Growth Rating: 53
SMR Rating: 47
Profit Risk Rating: 56
Seasonality Score: -28 (-100 ... +100)